ONWARD MEDICAL N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.69 EUR | +1.08% |
|
-7.68% | +51.29% |
| Apr. 25 | Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 02 | Onward Medical Seeks US FDA Nod to Market Spinal Cord Stimulation Therapy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Onward Medical N.V. is a medical technology company developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injury.
Calendar
2024-09-16
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.69
EUR
Average target price
13.85
EUR
Spread / Average Target
+195.31%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +51.29% | 173M | |
| +73.17% | 12.38B | |
| -18.74% | 7.92B | |
| +16.15% | 7.2B | |
| +4.81% | 5.84B | |
| +5.99% | 5.01B | |
| +27.07% | 4.53B | |
| -21.67% | 3.88B | |
| -40.82% | 2.23B | |
| +1.49% | 2.02B |
- Stock Market
- Equities
- ONWD Stock
- News Onward Medical N.V.
- Onward Medical Raises EUR20 Million Via Private, Public Offering of Shares
